Advantages and barriers of using telemedicine in the follow-up of patients with heart failure
DOI:
https://doi.org/10.33448/rsd-v10i9.17708Keywords:
Telemedicine; Telemonitoring; Heart failure.Abstract
Telemedicine is the remote delivery of health care services in situations that distance is a critical factor. Amidst of the COVID 19 scenario, telemedicine has undergone many advances, however, there are still obstacles in its applicability. In this context, the present study aims to conduct a systematic review focusing on the advantages and barriers of using telemedicine in monitoring patients with heart failure (HF). For this purpose, a bibliographic survey was carried out through the electronic library PubMed, having as inclusion criteria articles whose central theme was the use of telemedicine in monitoring patients with HF published between 2017 and 2021. In total, 95 articles were identified, of which only 13 had relevant contributions to the present study. Analyzing them, it was identified that the use of remote health services provides an increase in patient adherence to treatment, thus reducing the rate of hospitalization and death, in addition it has excellent cost-benefit. However, the impossibility of carrying out the physical examination and the population's lack of access to electronic devices and internet are obstacles that hinder its applicability. Therefore, despite the many benefits provided by telemedicine for patients with HF, well-established logistics are necessary for these barriers to be overcome.
References
Andrade, J. P. D., Mattos, L. A. P., Carvalho, A. C., Machado, C. A., & Oliveira, G. M. M. D. (2013). Programa nacional de qualificação de médicos na prevenção e atenção integral às doenças cardiovasculares. Arquivos Brasileiros de Cardiologia, 100(3), 203-211.
Brito, B. O., & Leitão, L. P. C. (2020). Telemedicina no Brasil: Uma estratégia possível para o cuidado em saúde em tempo de pandemia?. Saúde em Redes, 6(2 Suplem).
Chaet, D., Clearfield, R., Sabin, JE, & Skimming, K. (2017). Prática ética em telessaúde e telemedicina. Journal of general internal medicine, 32 (10), 1136-1140.
Ercole, F. F., Melo, L. S. D., & Alcoforado, C. L. G. C. (2014). Revisão integrativa versus revisão sistemática. Revista Mineira de Enfermagem, 18(1), 9-12.
Eurlings, CGMJ, Boyne, JJ, De Boer, RA e Brunner-La Rocca, HP (2019). Telemedicina na insuficiência cardíaca - mais do que bom ter?. Netherlands Heart Journal , 27 (1), 5-15.
Eyck, L.T., MacLeod, S., Hawkins, K., Guimont, R., & Hartley, S. (2019). The impact of a heart failure management program in a Medicare advantage population. Population health management, 22(2), 153-161.
Gensini, G. F., Alderighi, C., Rasoini, R., Mazzanti, M., & Casolo, G. (2017). Value of telemonitoring and telemedicine in heart failure management. Cardiac failure review, 3(2), 116.
Insuficiência, C. C. D. D., Colaboradores, C., & Rohde, L. E. P. (2018). Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda. Arq Bras Cardiol, 111(3), 436-539.
Kitsiou, S., Paré, G., & Jaana, M. (2015). Efeitos das intervenções de telemonitoramento domiciliar em pacientes com insuficiência cardíaca crônica: uma visão geral das revisões sistemáticas. Journal of medical Internet research, 17 (3), e63.
Koehler, F., Koehler, K., Deckwart, O., Prescher, S., Wegscheider, K., Kirwan, B. A., ... & Stangl, K. (2018). Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. The Lancet, 392(10152), 1047-1057.
Lin, M. H., Yuan, W. L., Huang, T. C., Zhang, H. F., Mai, J. T., & Wang, J. F. (2017). Clinical effectiveness of telemedicine for chronic heart failure: a systematic review and meta-analysis. Journal of Investigative Medicine, 65(5), 899-911.
Lopes, J. E., & Heimann, C. (2016). Uso das tecnologias da informação e comunicação nas ações médicas a distância: um caminho promissor a ser investido na saúde pública. Journal of Health Informatics, 8(1).
Lopes, M. A. C. Q., Oliveira, G. M. M. D., Ribeiro, A. L. P., Pinto, F. J., Rey, H. C. V., Zimerman, L. I., ... & Rezende, W. F. D. (2019). Guideline of the Brazilian Society of Cardiology on Telemedicine in Cardiology-2019. Arquivos brasileiros de cardiologia, 113(5), 1006-1056.
Maldonado, J. M. S. D. V., Marques, A. B., & Cruz, A. (2016). Telemedicina: desafios à sua difusão no Brasil. Cadernos de Saúde Pública, 32, e00155615.
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg, 8(5), 336-341.
Organização Mundial da saúde. (OMS). Digital Atlas Health. Internet. https://digitalhealthatlas.org/en//.
Organização Pan-Americana da Saúde. (OPS). Definição de indicadores para projetos de telemedicina como ferramenta para redução das iniquidades em saúde: documento de análise e resultados de uma comunidade de práticas. Washington D. C; 2016 [http://iris.paho.org/xmlui/handle/123456789/28563.
Tersalvi, G., Winterton, D., Cioffi, G. M., Ghidini, S., Roberto, M., Biasco, L., ... & Vicenzi, M. (2020). Telemedicine in heart failure during COVID-19: a step into the future. Frontiers in cardiovascular medicine, 7.
Vasconcelos, H. G., da Silva Vaz, S. H., Prado, L. F. R., Rezende, L. C., Machado, A. P. B., Pereira, D. F. G., ... & Andrade, V. F. (2020). Análise da mortalidade hospitalar por insuficiência cardíaca no estado de Minas Gerais, Brasil. Revista Eletrônica Acervo Científico, 12, e4568-e4568.
Veenis, JF, Radhoe, SP, Hooijmans, P., & Brugts, JJ (2021). Monitoramento remoto em pacientes com insuficiência cardíaca crônica: o monitoramento remoto não invasivo é o caminho a percorrer ?. Sensores, 21 (3), 887.
Vestergaard, A. S., Hansen, L., Sørensen, S. S., Jensen, M. B., & Ehlers, L. H. (2020). Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial. BMJ open, 10(1).
Zhu, Y., Gu, X., & Xu, C. (2020). Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials. Heart failure reviews, 25(2), 231-243.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Maysa Gabriela Costa Cruz; Lívia Ayres de Miranda Cavalcanti; Andressa Carneiro D'Albuquerque; Marilia Mendes Vasconcelos ; Renandro de Carvalho Reis
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
